These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2179788)

  • 21. Veralipride for hot flushes induced by a gonadotropin-releasing hormone agonist: a controlled study.
    Vercellini P; Sacerdote P; Trespidi L; Manfredi B; Panerai AE; Crosignani PG
    Fertil Steril; 1994 Nov; 62(5):938-42. PubMed ID: 7926138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The menopausal hot flush--anything new?
    Sturdee DW
    Maturitas; 2008 May; 60(1):42-9. PubMed ID: 18384981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause.
    Notelovitz M; Cassel D; Hille D; Furst KW; Dain MP; VandePol C; Skarinsky D
    Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):7-12. PubMed ID: 10649149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Menopausal flushes: effect of pituitary gonadotropin desensitization by a potent luteinizing hormone- releasing factor agonist.
    Casper RF; Yen SS
    J Clin Endocrinol Metab; 1981 Nov; 53(5):1056-8. PubMed ID: 6793613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Menopause and its sequelae: an interdisciplinary syndrome].
    Maurer-Major E; Küng F; Keller PJ
    Schweiz Med Wochenschr; 1998 Oct; 128(43):1697-702. PubMed ID: 9842669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Transdermal estrogen spray in therapy of postmenopausal syndrome].
    Fait T
    Ceska Gynekol; 2016 Jan; 81(1):77-80. PubMed ID: 26982070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Objectively recorded hot flushes in patients with pituitary insufficiency.
    Meldrum DR; Erlik Y; Lu JK; Judd HL
    J Clin Endocrinol Metab; 1981 Apr; 52(4):684-8. PubMed ID: 6782116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of sex steroids on pituitary responsiveness to gonadotropin releasing hormone.
    Eshkol A; Lunenfeld B; Insler V
    J Steroid Biochem; 1975 Jun; 6(6):1061-6. PubMed ID: 1100906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The flush revisited.
    van Leusden HA
    Eur J Obstet Gynecol Reprod Biol; 1994 Dec; 57(3):137-9. PubMed ID: 7713285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy on climacteric symptoms and safety of low dose estradiol transdermal matrix patches. A randomized, double-blind placebo-controlled study.
    De Aloysio D; Rovati LC; Giacovelli G; Setnikar I; Bottiglioni F
    Arzneimittelforschung; 2000 Mar; 50(3):293-300. PubMed ID: 10758784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical experience with a seven-day estradiol transdermal system for estrogen replacement therapy.
    Gordon SF
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 2):998-1004. PubMed ID: 7573298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of medroxyprogesterone acetate on gonadotropin secretion in girls with precocious puberty.
    Warren MP; Mathews JH; Morishima A; Vande Wiele R
    Am J Med Sci; 1975; 269(3):375-81. PubMed ID: 1155493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and local tolerance of a low-dose, 7-day matrix estradiol transdermal system in the treatment of menopausal vasomotor symptoms.
    Speroff L; Whitcomb RW; Kempfert NJ; Boyd RA; Paulissen JB; Rowan JP
    Obstet Gynecol; 1996 Oct; 88(4 Pt 1):587-92. PubMed ID: 8841224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The hot flash: pathophysiology and treatment.
    Frishman GN
    R I Med; 1995 May; 78(5):132-4. PubMed ID: 7606059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome.
    Berga SL; Yen SS
    Clin Endocrinol (Oxf); 1989 Feb; 30(2):177-84. PubMed ID: 2532984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic hyperestrogenemia: lack of positive feedback action on gonadotropin-releasing hormone-induced luteinizing hormone release and dual site of negative feedback action.
    Richardson DW; Gordon K; Billiar RB; Little AB
    Endocrinology; 1992 Mar; 130(3):1090-6. PubMed ID: 1537275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical usefulness of a low-dose maintenance therapy with transdermal estradiol gel in Japanese women with estrogen deficiency symptoms.
    Mizunuma H
    Climacteric; 2011 Oct; 14(5):581-9. PubMed ID: 21848497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral vasomotor control and menopausal flushing--a preliminary report.
    Brincat M; de Trafford JC; Lafferty K; Studd JW
    Br J Obstet Gynaecol; 1984 Nov; 91(11):1107-10. PubMed ID: 6498125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diethylstilbestrol in treatment of postorchiectomy vasomotor symptoms and its relationship with serum follicle-stimulating hormone, luteinizing hormone, and testosterone.
    Atala A; Amin M; Harty JI
    Urology; 1992 Feb; 39(2):108-10. PubMed ID: 1736500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subdermal estradiol pellets following hysterectomy and oophorectomy. Effect upon serum estrone, estradiol, luteinizing hormone, follicle-stimulating hormone, corticosteroid binding globulin-binding capacity, testosterone-estradiol binding globulin-binding capacity, lipids, and hot flushes.
    Lobo RA; March CM; Goebelsmann U; Krauss RM; Mishell DR
    Am J Obstet Gynecol; 1980 Nov; 138(6):714-9. PubMed ID: 6776814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.